AstraZeneca is in talks with the U.S. government to shift production of its COVID-19 vaccine from a troubled Baltimore plant to a new one in New Jersey. On Thursday, President Joe Biden announced a shipment of 25 million doses worldwide, though this won't include AstraZeneca doses. An error at the plant led AstraZeneca ingredients to contaminate J&J doses - ruining 15 million doses. These initial dose batches will be Pfizer, Moderna, or J&J because the FDA is still reviewing AstraZeneca doses produced at the Emergent plant. Still, some federal officials say the AstraZeneca doses may be useful in the U.S. if the company does apply for authorization.

Source: Daily Mail June 03, 2021 16:56 UTC